184 related articles for article (PubMed ID: 8563767)
1. Frequency of mutant CYP1A1, NAT2 and GSTM1 alleles in normal Indians and Malays.
Zhao B; Lee EJ; Wong JY; Yeoh PN; Gong NH
Pharmacogenetics; 1995 Oct; 5(5):275-80. PubMed ID: 8563767
[TBL] [Abstract][Full Text] [Related]
2. Genotype and allele frequencies of N-acetyltransferase 2 and glutathione S-transferase in the Iranian population.
Torkaman-Boutorabi A; Hoormand M; Naghdi N; Bakhshayesh M; Milanian I
Clin Exp Pharmacol Physiol; 2007 Nov; 34(11):1207-11. PubMed ID: 17880378
[TBL] [Abstract][Full Text] [Related]
3. Detection of mutations and polymorphism of N-acetyltransferase 1 gene in Indian, Malay and Chinese populations.
Zhao B; Lee EJ; Yeoh PN; Gong NH
Pharmacogenetics; 1998 Aug; 8(4):299-304. PubMed ID: 9731716
[TBL] [Abstract][Full Text] [Related]
4. Aromatic DNA adducts and polymorphisms of CYP1A1, NAT2, and GSTM1 in breast cancer.
Firozi PF; Bondy ML; Sahin AA; Chang P; Lukmanji F; Singletary ES; Hassan MM; Li D
Carcinogenesis; 2002 Feb; 23(2):301-6. PubMed ID: 11872636
[TBL] [Abstract][Full Text] [Related]
5. Candidate genetic modifiers of individual susceptibility to renal cell carcinoma: a study of polymorphic human xenobiotic-metabolizing enzymes.
Longuemaux S; Deloménie C; Gallou C; Méjean A; Vincent-Viry M; Bouvier R; Droz D; Krishnamoorthy R; Galteau MM; Junien C; Béroud C; Dupret JM
Cancer Res; 1999 Jun; 59(12):2903-8. PubMed ID: 10383153
[TBL] [Abstract][Full Text] [Related]
6. Association of CYP1A1, CYP1A2, GSTM1 and NAT2 gene polymorphisms with colorectal cancer and smoking.
Yoshida K; Osawa K; Kasahara M; Miyaishi A; Nakanishi K; Hayamizu S; Osawa Y; Tsutou A; Tabuchi Y; Shimada E; Tanaka K; Yamamoto M; Takahashi J
Asian Pac J Cancer Prev; 2007; 8(3):438-44. PubMed ID: 18159984
[TBL] [Abstract][Full Text] [Related]
7. Genotype and allele frequencies of isoniazid-metabolizing enzymes NAT2 and GSTM1 in Latvian tuberculosis patients.
Igumnova V; Capligina V; Krams A; Cirule A; Elferts D; Pole I; Jansone I; Bandere D; Ranka R
J Infect Chemother; 2016 Jul; 22(7):472-7. PubMed ID: 27236516
[TBL] [Abstract][Full Text] [Related]
8. Markers of genetic susceptibility in human environmental hygiene and toxicology: the role of selected CYP, NAT and GST genes.
Thier R; Brüning T; Roos PH; Rihs HP; Golka K; Ko Y; Bolt HM
Int J Hyg Environ Health; 2003 Jun; 206(3):149-71. PubMed ID: 12872524
[TBL] [Abstract][Full Text] [Related]
9. CYP1A1, CYP2D6, CYP2E1, NAT2, GSTM1 and GSTT1 polymorphisms or their combinations are associated with the increased risk of the laryngeal squamous cell carcinoma.
Gajecka M; Rydzanicz M; Jaskula-Sztul R; Kujawski M; Szyfter W; Szyfter K
Mutat Res; 2005 Jul; 574(1-2):112-23. PubMed ID: 15914211
[TBL] [Abstract][Full Text] [Related]
10. Pharmacogenetic profile of xenobiotic enzyme metabolism in survivors of the Spanish toxic oil syndrome.
Ladona MG; Izquierdo-Martinez M; Posada de la Paz MP; de la Torre R; Ampurdanés C; Segura J; Sanz EJ
Environ Health Perspect; 2001 Apr; 109(4):369-75. PubMed ID: 11335185
[TBL] [Abstract][Full Text] [Related]
11. Glutathione S transferase-theta (GSTT1) genetic polymorphism among Chinese, Malays and Indians in Singapore.
Lee EJ; Wong JY; Yeoh PN; Gong NH
Pharmacogenetics; 1995 Oct; 5(5):332-4. PubMed ID: 8563775
[TBL] [Abstract][Full Text] [Related]
12. Human drug-metabolizing enzyme polymorphisms: effects on risk of toxicity and cancer.
Nebert DW; McKinnon RA; Puga A
DNA Cell Biol; 1996 Apr; 15(4):273-80. PubMed ID: 8639263
[TBL] [Abstract][Full Text] [Related]
13. Risk of smoking for squamous and small cell carcinomas of the lung modulated by combinations of CYP1A1 and GSTM1 gene polymorphisms in a Japanese population.
Kihara M; Kihara M; Noda K
Carcinogenesis; 1995 Oct; 16(10):2331-6. PubMed ID: 7586131
[TBL] [Abstract][Full Text] [Related]
14. Arylamine N-acetyltransferase 1 (NAT1) and 2 (NAT2) polymorphisms in susceptibility to bladder cancer: the influence of smoking.
Okkels H; Sigsgaard T; Wolf H; Autrup H
Cancer Epidemiol Biomarkers Prev; 1997 Apr; 6(4):225-31. PubMed ID: 9107426
[TBL] [Abstract][Full Text] [Related]
15. Frequency of mutant CYPIA1, NAT2 and GSTM1 alleles in a normal Chinese population.
Lee EJ; Zhao B; Moochhala SM; Ngoi SS
Pharmacogenetics; 1994 Dec; 4(6):355-8. PubMed ID: 7704042
[No Abstract] [Full Text] [Related]
16. Polymorphisms of N-acetyltransferases, glutathione S-transferases, microsomal epoxide hydrolase and sulfotransferases: influence on cancer susceptibility.
Hengstler JG; Arand M; Herrero ME; Oesch F
Recent Results Cancer Res; 1998; 154():47-85. PubMed ID: 10026993
[TBL] [Abstract][Full Text] [Related]
17. Polymorphic enzymes of xenobiotic metabolism as modulators of acquired P53 mutations in bladder cancer.
Brockmöller J; Kaiser R; Kerb R; Cascorbi I; Jaeger V; Roots I
Pharmacogenetics; 1996 Dec; 6(6):535-45. PubMed ID: 9014203
[TBL] [Abstract][Full Text] [Related]
18. Polymorphisms of glutathione-S-transferase and arylamine N-acetyltransferase enzymes and susceptibility to colorectal cancer.
Kiss I; Németh A; Bogner B; Pajkos G; Orsós Z; Sándor J; Csejtey A; Faluhelyi Z; Rodler I; Ember I
Anticancer Res; 2004; 24(6):3965-70. PubMed ID: 15736440
[TBL] [Abstract][Full Text] [Related]
19. Genotyping for polymorphisms in xenobiotic metabolism as a predictor of disease susceptibility.
Daly AK; Cholerton S; Armstrong M; Idle JR
Environ Health Perspect; 1994 Nov; 102 Suppl 9(Suppl 9):55-61. PubMed ID: 7698086
[TBL] [Abstract][Full Text] [Related]
20. Combined analysis of inherited polymorphisms in arylamine N-acetyltransferase 2, glutathione S-transferases M1 and T1, microsomal epoxide hydrolase, and cytochrome P450 enzymes as modulators of bladder cancer risk.
Brockmöller J; Cascorbi I; Kerb R; Roots I
Cancer Res; 1996 Sep; 56(17):3915-25. PubMed ID: 8752158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
